Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece.

Autor: Barmpouni M; Pfizer Hellas, Athens, Greece., Gordon JP; Health Economics and Outcomes Research Ltd., Cardiff, UK., Miller RL; Health Economics and Outcomes Research Ltd., Cardiff, UK., Dennis JW; Health Economics and Outcomes Research Ltd., Cardiff, UK., Grammelis V; Pfizer Hellas, Athens, Greece., Rousakis A; Pfizer Hellas, Athens, Greece., Souliotis K; Faculty of Social and Political Sciences, University of Peloponnese, Corinth, Greece.; Health Policy Institute, Athens, Greece., Poulakou G; 3rd Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria General Hospital, Athens, Greece., Daikos GL; National and Kapodistrian University of Athens, Athens, Greece., Al-Taie A; Pfizer R&D, Pfizer Ltd, Dorking Road, Tadworth, KT20 7NT, UK. Amer.Taie@Pfizer.com.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2023 Jul; Vol. 12 (7), pp. 1891-1905. Date of Electronic Publication: 2023 Jul 06.

Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options.

Autor: Barmpouni M; Pfizer Hellas, Athens, Greece., Gordon JP; Health Economics and Outcomes Research Ltd., Cardiff, UK., Miller RL; Health Economics and Outcomes Research Ltd., Cardiff, UK., Pritchard CRJ; Health Economics and Outcomes Research Ltd., Cardiff, UK., Dennis JW; Health Economics and Outcomes Research Ltd., Cardiff, UK., Grammelis V; Pfizer Hellas, Athens, Greece., Rousakis A; Pfizer Hellas, Athens, Greece., Souliotis K; Faculty of Social and Political Sciences, University of Peloponnese, Corinth, Greece.; Health Policy Institute, Athens, Greece., Poulakou G; 3rd Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria General Hospital, Athens, Greece., Daikos GL; First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Al-Taie A; Pfizer R&D, Pfizer Ltd, Dorking Road, Tadworth, KT20 7NT, UK. Amer.Taie@Pfizer.com.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2023 Feb; Vol. 12 (2), pp. 527-543. Date of Electronic Publication: 2022 Dec 21.

EE452 Cost-Effectiveness Analysis of Introducing Ceftazidime-Avibactam to Treatment Strategies for Hospital-Acquired Infections in Greece

Autor: Barmpouni, M, Grammelis, V, Rousakis, A, Miller, R, Pritchard, C, Dennis, J, Al Taie, A

Publikováno v: In Value in Health December 2022 25(12) Supplement:S144-S144

PIN26 ESTIMATING THE INVASIVE CANDIDIASIS COST-OF-CARE IN INTENSIVE CARE UNITS IN GREECE (HELICAS)

Autor: Armaganidis, A., Tsilakis, D., Skiadas, I., Cheliotis, G., Anisoglou, S., Alamanos, I., Baltopoulos, G., Fligou, F., Floros, I., Georgopoulos, D., Gerogianni, N., Koutsoukou, A., Mandragos, K., Mathas, C., Mavrommatis, A., Michalia, M., Bitzani, M., Pnevmatikos, I., Prekates, A., Tsakris, A., Zakynthinos, E., Zakynthinos, S., Kostagiolas, L., Grammelis, V.

Publikováno v: In Value in Health November 2019 22 Supplement 3:S644-S644

Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003

Autor: Souli, M. Volonakis, K. Kapaskelis, A. Galani, I. and Grammelis, V. Vorou, R. Tsivra, M. Chryssouli, Z. and Katsala, D. Giamarellou, H.

Nasopharyngeal Streptococcus pneumoniae isolates colonising young children are representative of isolates causing clinical disease. This study determined the frequency of macrolide-non-susceptible pneumococci, as well as their phenotypic and genotypi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::9485300b24baa12a1bde551015db0431
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3115486